US Patent 10975390 Targeted modification of rat genome
Patent 10975390 was granted and assigned to Regeneron Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10975390 Targeted modification of rat genome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
